-+ 0.00%
-+ 0.00%
-+ 0.00%

PRAXIS PRECISION MEDICINES ANNOUNCES PLANS TO FILE AN NDA FOR RELUTRIGINE IN SCN2A AND SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES IN EARLY 2026

路透·12/11/2025 13:00:04

登錄查看新聞詳情